Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Chlordiazepoxide

Hoda H. Ahwazi  1 , Preeti Patel, Sara Abdijadid  2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan.
.
Affiliations
Free Books & Documents
Book

Chlordiazepoxide

Hoda H. Ahwazi et al.
Free Books & Documents

Excerpt

Chlordiazepoxide belongs to the category of long-acting benzodiazepines and is approved by the US Food and Drug Administration (FDA) for the management of mild-to-severe anxiety, preoperative anxiety, and alcohol withdrawal in adults. Although chlordiazepoxide was synthesized and developed in 1956, it was approved for use in 1960. The drug is considered one of the safest and most effective benzodiazepine composites among psychopharmacological compounds. In addition, this medication is FDA-approved for anxiety in pediatric patients aged 6 and older.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Hoda Ahwazi declares no relevant financial relationships with ineligible companies.

Disclosure: Preeti Patel declares no relevant financial relationships with ineligible companies.

Disclosure: Sara Abdijadid declares no relevant financial relationships with ineligible companies.

References

    1. The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. J Addict Med. 2020 May/Jun;14(3S Suppl 1):1-72. - PubMed
    1. Zhao Y, Bijlsma EY, Verdouw PM, Garssen J, Groenink L. The contribution of contextual fear in the anxiolytic effect of chlordiazepoxide in the fear-potentiated startle test. Behav Brain Res. 2018 Nov 01;353:57-61. - PubMed
    1. Girish K, Vikram Reddy K, Pandit LV, Pundarikaksha HP, Vijendra R, Vasundara K, Manjunatha R, Nagraj M, Shruthi R. A randomized, open-label, standard controlled, parallel group study of efficacy and safety of baclofen, and chlordiazepoxide in uncomplicated alcohol withdrawal syndrome. Biomed J. 2016 Feb;39(1):72-80. - PMC - PubMed
    1. Dold M, Bartova L, Fugger G, Mitschek MMM, Kautzky A, Frey R, Montgomery S, Zohar J, Mendlewicz J, Souery D, Fabbri C, Serretti A, Kasper S. Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study. Eur Neuropsychopharmacol. 2020 Dec;41:70-80. - PubMed
    1. Goldschen-Ohm MP. Benzodiazepine Modulation of GABAA Receptors: A Mechanistic Perspective. Biomolecules. 2022 Nov 30;12(12) - PMC - PubMed

Publication types

LinkOut - more resources